Skip to content
2000
Volume 9, Issue 3
  • ISSN: 1874-4710
  • E-ISSN: 1874-4729

Abstract

There are new efforts to develop “sugar” probes for molecular imaging focusing on human clinical studies. Radiolabeled carbohydrates are used as substrate probes for studying specific processes in tissues and organisms. The best application case is 2-Deoxy-2-[18F]fluoro-D-glucose (18F-FDG), which is incorporated by cancer cells. The introduction of 18F-FDG has advanced enormously human Positron Emission Tomography (PET). This review focuses on the importance of 18FFDG and other sugars as imaging probes in PET and Single Photon Emission Computed Tomography (SPECT) imaging. In conclusion, new radiolabeled molecules that can be used as radiopharmaceuticals also would possibly help in the treatment of cancer cells in human patients.

Loading

Article metrics loading...

/content/journals/crp/10.2174/1874471008666150525104725
2016-12-01
2025-09-27
Loading full text...

Full text loading...

/content/journals/crp/10.2174/1874471008666150525104725
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test